Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy

Area of Science:

• Urology
• Oncology
• Surgical Oncology

Background:

• Extended pelvic lymph node dissection (ePLND) is controversial in localized prostate cancer management.
• While beneficial for staging and prognostication, its role in cancer control is debated due to potential perioperative morbidity.
• Adoption of ePLND in the robotic surgery setting has been slow.

Approach:

• This study synthesizes existing evidence on the prognostic and therapeutic value of ePLND.
• It reviews clinical tools utilized for predicting lymph node metastasis.
• The experiences of robotic urologic surgeons with ePLND are surveyed.

Key Points:

• ePLND offers crucial staging and prognostic information in prostate cancer.
• The therapeutic benefit of ePLND for cancer control remains under investigation.
• Predictive tools can help identify patients most likely to benefit from ePLND.
• Robotic surgery presents unique considerations for ePLND adoption and technique.

Conclusions:

• Further research is needed to clarify the definitive role of ePLND in prostate cancer treatment.
• Optimizing patient selection for ePLND is essential to balance benefits and risks.
• Robotic surgery may offer new avenues for performing ePLND with potentially reduced morbidity.